Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development
Abstract Background The mRNA-based cancer vaccine has been considered a promising strategy and the next hotspot in cancer immunotherapy. However, its application on cholangiocarcinoma remains largely uncharacterized. This study aimed to identify potential antigens of cholangiocarcinoma for developme...
Main Authors: | Xing Huang, Tianyu Tang, Gang Zhang, Tingbo Liang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | Molecular Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12943-021-01342-6 |
Similar Items
-
Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine
by: Hua Zhong, et al.
Published: (2021-08-01) -
Recognition of Tumor-Associated Antigens and Immune Subtypes in Glioma for mRNA Vaccine Development
by: Shuai Ma, et al.
Published: (2021-09-01) -
Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development
by: Xing Huang, et al.
Published: (2021-03-01) -
Neo-Antigen mRNA Vaccines
by: Arthur Esprit, et al.
Published: (2020-12-01) -
Influenza Viruses: Innate Immunity and mRNA Vaccines
by: SangJoon Lee, et al.
Published: (2021-08-01)